EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tau seeding without tauopathy

Michael S LaCroix, Efrosini Artikis, Brian D Hitt, Joshua D Beaver, Sandi-Jo Estill-Terpack, Kelly Gleason, Carol A Tamminga, Bret M Evers, Charles L White, Byron Caughey, Marc I Diamond

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2023.105545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Michael S LaCroix und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Tauopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative tauopathies such as Alzheimer's disease (AD) are caused by brain accumulation of tau assemblies. Evidence suggests tau functions as a prion, and cells and animals can efficiently propagate unique, transmissible tau pathologies. This suggests a dedicated cellular replication machinery, potentially reflecting a normal physiologic function for tau seeds. Consequently, we hypothesized that healthy control brains would contain seeding activity. We have recently developed a novel monoclonal antibody (MD3.1) specific for tau seeds. We used this antibody to immunopurify tau from the parietal and cerebellar cortices of 19 healthy subjects without any neuropathology, ranging 19 to 65 years. We detected seeding in lysates from the parietal cortex, but not in the cerebellum. We also detected no seeding in brain homogenates from wildtype or human tau knockin mice, suggesting that cellular/genetic context dictates development of seed-competent tau. Seeding did not correlate with subject age or brain tau levels. We confirmed our essential findings using an orthogonal assay, real-time quaking-induced conversion, which amplifies tau seeds in vitro. Dot blot analyses revealed no AT8 immunoreactivity above background levels in parietal and cerebellar extracts and ∼1/100 of that present in AD. Based on binding to a panel of antibodies, the conformational characteristics of control seeds differed from AD, suggesting a unique underlying assembly, or structural ensemble. Tau's ability to adopt self-replicating conformations under nonpathogenic conditions may reflect a normal function that goes awry in disease states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseTauopathiesAnimalsHumansMiceBrainCerebellumtau ProteinsMaleFemaleYoung AdultAdultMiddle AgedAged

Stichwörter der Autor:innen

Alzheimer’s diseaseFRET biosensorhealthy brainpriontau seeding activitytauopathy

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • NIH/NIAID, Rocky Mountain Laboratories, Hamilton, Montana, USA.
  • Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA; Department of Neurology, UT Southwestern Medical Center, D…
  • Department of Psychiatry, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.

Förderung

  • NIA NIH HHS
  • National Institute on Aging
  • National Institute of Allergy and Infectious Diseases
  • Communities Foundation of Texas
  • McCune Foundation
  • Chan Zuckerberg Initiative
  • National Institutes of Health

Zitieren

APA

LaCroix, M. S., Artikis, E., Hitt, B. D., Beaver, J. D., Estill-Terpack, S. J., Gleason, K., Tamminga, C. A., Evers, B. M., White, C. L., Caughey, B., & Diamond, M. I. (2024). Tau seeding without tauopathy. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105545

Vancouver

LaCroix MS, Artikis E, Hitt BD, Beaver JD, Estill-Terpack SJ, Gleason K, et al. Tau seeding without tauopathy. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2023.105545

BibTeX
@article{LaCroix2024,
  author = {LaCroix, Michael S and Artikis, Efrosini and Hitt, Brian D and Beaver, Joshua D and Estill-Terpack, Sandi-Jo and Gleason, Kelly and Tamminga, Carol A and Evers, Bret M and White, Charles L and Caughey, Byron and Diamond, Marc I},
  title = {Tau seeding without tauopathy},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2023.105545}
}
Kostenlos starten →